Prevalence of Neuropathic Component in Post-COVID Pain Symptoms in Previously Hospitalized COVID-19 Survivors

Table 2

Pearson-product moment correlation matrix between sociodemographic, psychological, neurophysiological, and clinical characteristics.

	1	2	3	4	5	6	7	8	9
1. Age
2. Weight	n.s.
3. Height	n.s.	0.521
4. Time with symptoms	n.s.	n.s.	n.s.
5. Mean pain intensity	n.s.	n.s.	n.s.	n.s.
6. HADS-A	n.s.	n.s.	n.s.	n.s.	n.s.
7. HADS-D	n.s.	n.s.	n.s.	n.s.	0.301	0.867
8. PCS	n.s.	n.s.	n.s.	n.s.	0.321	0. 672	0.619
9. TKS-11	n.s.	n.s.	n.s.	n.s.	0.429	0.409	0.365	0.639
10. S-LANSS	n.s.	n.s.	n.s.	0.262	n.s.	0.275	n.s.	n.s.	0.291

S-LANSS, Self-report Leeds Assessment of Neuropathic Symptoms and Signs; HADS, Hospital Anxiety and Depression Scale; PCS, Pain Catastrophizing Scale; TSK-11: Tampa Scale for Kinesiophobia.  < 0.05;  < 0.01.